280 related articles for article (PubMed ID: 24183331)
1. The politics of providing opioid pharmacotherapy.
Radcliffe P; Parkes T
Int J Drug Policy; 2013 Nov; 24(6):e6-10. PubMed ID: 24183331
[No Abstract] [Full Text] [Related]
2. Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the "small stuff" in a liberal paradise.
Treloar C; Valentine K
Int J Drug Policy; 2013 Nov; 24(6):e11-3. PubMed ID: 23711673
[No Abstract] [Full Text] [Related]
3. Opioid pharmacotherapy: Treatment, regimes, constructions and control.
Neale J
Int J Drug Policy; 2013 Nov; 24(6):e1-5. PubMed ID: 24075399
[No Abstract] [Full Text] [Related]
4. The role of the Chinese police in methadone maintenance therapy: a literature review.
Meng J; Burris S
Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
[TBL] [Abstract][Full Text] [Related]
5. Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic.
Crawford S
Int J Drug Policy; 2013 Nov; 24(6):e14-7. PubMed ID: 24007689
[TBL] [Abstract][Full Text] [Related]
6. Methadone, a contested substance: Danish methadone policy in the 1970s.
Houborg E
Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
[TBL] [Abstract][Full Text] [Related]
7. Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.
Bernstein SE; Bennett D
Int J Drug Policy; 2013 Nov; 24(6):e61-5. PubMed ID: 23680227
[TBL] [Abstract][Full Text] [Related]
8. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
[TBL] [Abstract][Full Text] [Related]
9. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
[TBL] [Abstract][Full Text] [Related]
10. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
Ferrara MM
Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
[No Abstract] [Full Text] [Related]
11. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.
Schmidt CS; Schulte B; Wickert C; Thane K; Kuhn S; Verthein U; Reimer J
Int J Drug Policy; 2013 Nov; 24(6):e111-4. PubMed ID: 23726899
[No Abstract] [Full Text] [Related]
12. Increasing access to opioid maintenance treatment: the role of primary care in France.
Roux P; Lions C; Carrieri MP
Int J Drug Policy; 2015 Apr; 26(4):434-5. PubMed ID: 25683137
[No Abstract] [Full Text] [Related]
13. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
Monaghan M; Wincup E
Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
[TBL] [Abstract][Full Text] [Related]
14. The marketing of methadone: how an effective medication became unpopular.
Bruce RD
Int J Drug Policy; 2013 Nov; 24(6):e89-90. PubMed ID: 24246504
[No Abstract] [Full Text] [Related]
15. Drugs for opioid Use disorder.
Med Lett Drugs Ther; 2017 Jun; 59(1522):89-95. PubMed ID: 28609420
[No Abstract] [Full Text] [Related]
16. The science and practice of medication-assisted treatments for opioid dependence.
Pecoraro A; Ma M; Woody GE
Subst Use Misuse; 2012; 47(8-9):1026-40. PubMed ID: 22676570
[TBL] [Abstract][Full Text] [Related]
17. Palliative care in India suffers due to cumbersome rules.
Sharma DC
Lancet Oncol; 2014 Feb; 15(2):e54. PubMed ID: 24627907
[No Abstract] [Full Text] [Related]
18. Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.
Med Lett Drugs Ther; 2018 Feb; 60(1541):35-37. PubMed ID: 29485976
[No Abstract] [Full Text] [Related]
19. Response to Chandler et al., Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
Valentine K; Treloar C
Int J Drug Policy; 2013 Nov; 24(6):e87-8. PubMed ID: 23931956
[No Abstract] [Full Text] [Related]
20. [Complementary medicine as political process. Swiss public opinion on the "Future with Complementary Medicine"].
Rist L; Schwabl H
Forsch Komplementmed; 2009 Apr; 16(2):76-8. PubMed ID: 19420952
[No Abstract] [Full Text] [Related]
[Next] [New Search]